Embramine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H22BrNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HH0KD7Z416, chemically known as 2-(p-bromo-alpha-methyl-alpha-phenylbenzyloxy)-n,n-dimethylethyl amine but generally known as embramine, which bears US NIH Compound Identifier 19105. European Medicines Agency schedules Embramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06500MIG. The term EMBRAMINE is an International Non-Proprietary Name. EMBRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule embramine under HS 29221980 and SITC 51461. As of Q4 2014, EMBRAMINE remains the US FDA Preferred Term for this commodity. Embramine bears US NLM identifiers UMLS ID C0059053 and NCI Concept Code C81150. SMILES: BRC1CCC(C(OCCN(C)C)(C2CCCCC2)C)CC1.